These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 2119395)

  • 21. Chronic liver disease in transfusion-dependent thalassaemia: hepatitis B virus marker studies.
    De Virgiliis S; Fiorelli G; Fargion S; Cornacchia G; Sanna G; Cossu P; Murgia V; Cao A
    J Clin Pathol; 1980 Oct; 33(10):949-53. PubMed ID: 7430360
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Chronic non-A, non-B hepatitis: role of hepatitis C virus.
    Iorio R; Guida S; Porzio S; Fariello I; Vegnente A
    Arch Dis Child; 1993 Feb; 68(2):219-22. PubMed ID: 7683189
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Serum ferritin, liver iron stores, and liver histology in children with thalassaemia.
    de Virgiliis S; Sanna G; Cornacchia G; Argiolu F; Murgia V; Porcu M; Cao A
    Arch Dis Child; 1980 Jan; 55(1):43-5. PubMed ID: 7377816
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prevalence of anti-HCV in cryptogenic cirrhosis in a suburban Detroit community.
    Barnes RE; Meyer RA; Gordon SC
    Am J Gastroenterol; 1992 Aug; 87(8):1001-4. PubMed ID: 1379412
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Does hepatitis C virus play a role in "non-viral" chronic liver disease?
    Liddle C; Crewe EB; Swanson NR; Jeffrey GP; Cunningham AL; Reed WD; Batey RG; Farrell GC
    Med J Aust; 1990 Sep; 153(5):265-71. PubMed ID: 2118225
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Decreased serum aminotransferase activity in patients with chronic renal failure: impact on the detection of viral hepatitis.
    Fabrizi F; Lunghi G; Finazzi S; Colucci P; Pagano A; Ponticelli C; Locatelli F
    Am J Kidney Dis; 2001 Nov; 38(5):1009-15. PubMed ID: 11684554
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Primary carcinoma of the liver and hepatitis C virus in Italy. A prospective study in patients with cirrhosis].
    Bargiggia S; Piva A; Sangiovanni A; Donato F
    Medicina (Firenze); 1989; 9(4):424-6. PubMed ID: 2561301
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Hepatitis C in sickle cell anemia.
    DeVault KR; Friedman LS; Westerberg S; Martin P; Hosein B; Ballas SK
    J Clin Gastroenterol; 1994 Apr; 18(3):206-9. PubMed ID: 8034915
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prevalence of hepatitis C in transfusion dependent thalassaemics & haemophilics.
    Bhattacharya DK; Bhattacharjee S; De M; Lahiri P
    Indian J Med Res; 1991 Dec; 94():430-2. PubMed ID: 1774095
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Non-A, non-B hepatitis and antibody to hepatitis C virus.
    Mosley JW; Aach RD; Hollinger FB; Stevens CE; Barbosa LH; Nemo GJ; Holland PV; Bancroft WH; Zimmerman HJ; Kuo G
    JAMA; 1990 Jan; 263(1):77-8. PubMed ID: 2104549
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Long-term outcome in kidney transplant patients with hepatitis C (HCV) infection.
    Orloff SL; Stempel CA; Wright TL; Tomlanovich SJ; Amend WJ; Stock PG; Melzer JS; Vincenti F
    Clin Transplant; 1995 Apr; 9(2):119-24. PubMed ID: 7599400
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effect of deferiprone on liver iron overload and fibrosis in hepatitis-C-virus-infected thalassemia.
    Chen AC; Peng CT; Wu SF; Wu KH; Chiang IP; Tsai CH
    Hemoglobin; 2006; 30(2):209-14. PubMed ID: 16798645
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Hepatitis C virus infection in thalassemia patients undergoing allogeneic bone marrow transplantation.
    Erer B; Angelucci E; Lucarelli G; Giardini C; Baronciani D; Galimberti M; Polchi P; Amadei G; Battistini L; Paolucci S
    Bone Marrow Transplant; 1994 Sep; 14(3):369-72. PubMed ID: 7527690
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Post-transfusion hepatitis C virus infection among β-thalassaemic individuals with associated clinical parameters.
    Biswas A; Firdaus R; Saha K; Chowdhury P; Bhattacharya D; Bhattacharyya M; Sadhukhan PC
    Indian J Med Res; 2018 Jun; 147(6):581-587. PubMed ID: 30168490
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Serological responses to hepatitis B virus infection in multi-transfused thalassemic children.
    Gulati S; Marwaha RK; Dilawari JB; Midha U; Walia BN
    Indian Pediatr; 1992 Jan; 29(1):73-7. PubMed ID: 1601501
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The presence of anti-HCV antibodies in the serum of patients with chronic active hepatitis and antinuclear antibodies.
    Roget M; Buti M; Esteban JI; Esteban R; Guardia J
    Hepatology; 1990 Feb; 11(2):333-5. PubMed ID: 2106476
    [No Abstract]   [Full Text] [Related]  

  • 37. HLA class II genes in chronic hepatitis C virus-infection and associated immunological disorders.
    Congia M; Clemente MG; Dessi C; Cucca F; Mazzoleni AP; Frau F; Lampis R; Cao A; Lai ME; De Virgiliis S
    Hepatology; 1996 Dec; 24(6):1338-41. PubMed ID: 8938157
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prevalence of antibodies to hepatitis C virus in Chinese patients with viral hepatitis and hepatic failure.
    Zhang DF; Zhou YS; Jia XP
    Chin Med J (Engl); 1992 Jul; 105(7):539-43. PubMed ID: 1451557
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Antibody responses to hepatitis C virus and its modes of transmission in dialysis patients.
    Almroth G; Ekermo B; Franzén L; Hed J
    Nephron; 1991; 59(2):232-5. PubMed ID: 1659671
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prevalence and significance of HCV infection in a consecutive series of patients with HBV antibodies and raised aminotransferases.
    Delle Monache M; Santolamazza M; Marinelli RM; Ricci GL
    Ital J Gastroenterol; 1991; 23(3):140-1. PubMed ID: 1660329
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.